Medical News Podcast
Today: #153 in Health & Fitness, Japan on our combined chart.
Chart positions today · United Kingdom
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Medical News Podcast, try…
Ranking history · United Kingdom
Latest episodes
-
When an antidepressant lengthens the QT interval, does that translate into more cardiovascular events?
October 6, 2026 · 4 minThis episode reviews randomized-trial analyses of antidepressant-related QTc changes and early cardiovascular events; an observational study of buprenorphine initiation during concurrent alcohol and opioid withdrawal; and a target-trial…
-
Perspectives in Personalizing Treatment in ILD
October 5, 2026 · 13 minDrs. Martinez and Montesi discuss how to personalize treatment for ILD, particularly IPF. They explain that current personalization is largely driven by side effects, insurance constraints, and patient preferences, emphasizing the need to…
-
Optimizing Control: Combining Biologics With Non-Systemic Strategies in Atopic Dermatitis
September 30, 2026 · 6 minDrs. Lio and Yosipovitch discuss that while biologic therapy has greatly improved atopic dermatitis control, many patients still struggle with residual itch, sleep disruption, and intermittent flares that impact daily life. They explain…
-
What does a major change in the Jehovah’s Witness position on blood components mean for emergency and surgical care?
September 29, 2026 · 5 minThis episode covers the Jehovah’s Witness policy change making acceptance of donor blood components an individual conscience decision; a study associating short oral steroid courses with serious adverse events in adults with type 2…
-
Could a new neuroprotective drug improve recovery even when given as long as 48 hours after an ischemic stroke?
September 24, 2026 · 4 minThis episode reviews a randomized phase 3 trial suggesting that loberamisal may improve functional recovery following acute ischemic stroke; a SELECT trial analysis examining the efficacy and safety of semaglutide across different levels…
Show 7 more episodesShow fewer episodes
-
Thrombosis & Bleeding in CLL: Risk, Mechanisms, and Practical Management in the Targeted-Therapy Era
September 23, 2026 · 11 minDrs. Scarfò and Ghia discuss how CLL creates a delicate balance between blood clots and bleeding, a challenge made more complex by BTK inhibitors and common comorbidities in older patients. They explore how careful risk assessment…
-
What new guidance could change RSV prevention for infants and high-risk children this fall?
September 17, 2026 · 5 minThis episode reviews updated AAP recommendations for RSV prevention in infants and high-risk children entering a second RSV season, phase 3 data suggesting TP53 mutation status may help identify patients with EGFR-mutated advanced…
-
Beyond Sudden Death: New Risk Markers in Hypertrophic Cardiomyopathy
September 9, 2026 · 10 minDrs. Owens and de Feria review emerging data on epicardial adipose tissue and MRI-based markers to refine hypertrophic cardiomyopathy risk assessment. They highlight integrating imaging and biomarkers, including NT‑proBNP, to predict heart…
-
Avoiding Diagnostic Pitfalls in ATTR-CM: Getting the Diagnosis Right the First Time
September 8, 2026 · 13 minDrs. Kittleson and Ghafourian discuss how to accurately diagnose ATTR-CM, emphasizing that the first step must always be a complete monoclonal protein screen to exclude AL amyloidosis before interpreting a PYP scan. They highlight common…
-
Choosing Among Asthma Biologics
September 7, 2026 · 12 minDrs. Chase and Griffiths discuss how to choose biologic therapies for allergic asthma using a personalized approach based on biomarkers, asthma severity, comorbid type 2 diseases, and practical factors (eg, dosing and access). They…
-
With the new school year underway, what health concerns should pediatric clinicians keep on their radar?
September 4, 2026 · 5 minThis episode highlights back-to-school vaccination priorities amid updated pediatric guidance and ongoing measles activity, new evidence linking adolescent sleep disruption and school transitions with anxiety and declining well-being, and…
-
Could the FDA’s first-in-class RAS inhibitor approval mark a turning point in metastatic pancreatic cancer?
September 3, 2026 · 5 minThis episode highlights FDA approval of the first-in-class RAS inhibitor daraxonrasib for metastatic pancreatic adenocarcinoma, concerning gaps in cervical cancer screening and HPV vaccination among younger women, and new evidence defining…